Biology and Diagnosis: How the Immune Defect Works

While a diagnosis of Immunodeficiency 89 (IMD89) is confirmed through genetic testing, the “footprints” of the disease are found in your child’s blood. Doctors use specialized laboratory tests to look at the biology of the immune system to understand why it isn’t protecting the body as it should.

The Biology of the “Control Switch”

The IKZF3 gene is responsible for creating a protein called AIOLOS. Think of AIOLOS as a control switch or transcription factor ^[1]. Its job is to sit on specific parts of your child’s DNA and turn other genes “on” or “off” to help white blood cells (lymphocytes) grow and mature ^[2][3].

In IMD89, a mutation in the gene creates a “broken” version of the AIOLOS protein. In most cases, this follows a dominant-negative mechanism ^[1][4]. This means the broken protein doesn’t just sit idle; it actively gets in the way of the healthy AIOLOS protein, preventing the switch from working correctly ^[1]. Two well-known mutations that act this way are p.Asn160Ser and p.Gly191Arg ^[1][4].

Laboratory Hallmarks: Flow Cytometry

To see how these broken switches affect the immune system, doctors use flow cytometry, a laser-based technology that counts and sorts different types of immune cells. In a child with IMD89, the results may show an abnormal “profile,” though this varies depending on the specific variant and age:

• Memory B-Cell Depletion: B cells are the cells that “remember” germs. In this condition, there may be a marked reduction in switched-memory B cells, meaning the body struggles to keep a long-term library of how to fight infections ^[1][4].
• CD21-low B Cells: Doctors often find an increase in a specific type of B cell called CD21-low cells ^[1].
• Minimal CD23 Expression: Some children show a significant lack of a marker called CD23 on the surface of B cells ^[1][4].
• T-Cell Imbalance: The T-cell side of the immune system may show too many naive cells (cells that haven’t learned to fight anything yet) and too few memory T cells (experienced fighters) ^[1][4].

Antibodies and Vaccine Responses

Because the switch for B cells is broken, the body may struggle to produce enough immunoglobulins (antibodies). This is called hypogammaglobulinemia ^[5].

When doctors test how a child with IMD89 responds to vaccines, they often find that the body fails to make protective antibodies (low titers) ^[1]. Even if your child received all their standard childhood shots, their blood may show that the protection never “took” or has already faded away ^[1]. It is important to know that if your child is receiving IVIG or SCIG, donor antibodies can make these results very difficult to interpret. Always rely on your immunologist to evaluate them.

Distinguishing IMD89 from Other Conditions

IMD89 can look very similar to other immune disorders, such as Common Variable Immunodeficiency (CVID). However, because IMD89 affects both T and B cells (a “combined” immunodeficiency), it requires management based on the actual immune phenotype and clinical course ^[1].

Examples for Diagnostic Discussion

To ensure your child has a complete diagnostic picture, you can use the following tests as discussion points with your team:

1. Flow Cytometry Lymphocyte Subsets: Specifically looking for B-cell markers (CD21, CD23, memory cells) and T-cell maturity ^[1][4].
2. Quantitative Immunoglobulins: A measurement of total IgG, IgA, IgM, and IgE levels ^[5].
3. Vaccine-Specific Antibody Titers: Tests to see if the body responded to vaccines like Tetanus, Diphtheria, or Pneumococcus ^[1].
4. Confirmatory Genetic Sequencing: Detailed sequencing (like Whole Exome Sequencing or targeted panels) to identify the specific mutation in the IKZF3 gene ^[1][4]. Importantly, a “Variant of Uncertain Significance” (VUS) does not confirm the diagnosis; the variant must be classified as pathogenic or likely pathogenic and correlate with the clinical picture.

Understanding these results helps the medical team move from a general diagnosis to a precise treatment plan tailored to your child’s specific immune “profile.”